Groowe Groowe / Newsroom / NVS
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NVS News

Novartis AG

Diabetic Macular Edema Market - A Global and Regional Analysis: Focus on Route of Administration, Distribution Channel, and Region, 2025-2035

globenewswire.com
ROG NVS PFE

North America Leads Gene Therapy Market Due to Rising Genetic Disorders

globenewswire.com
NVS

App Test Automation Industry Research 2026 - Global Market Size, Share, Trends, Opportunities, and Forecasts, 2021-2025 & 2026-2031

globenewswire.com
LOGI MSFT GOOG AMZN IBM ORCL INTC NVDA CRM ADBE SAP EA TTWO ROKU NFLX DIS CMCSA TCOM MELI SHOP PYPL UBER LYFT DDOG PANW CRWD ZS NOW TWLO SNOW PLTR AI STX WDC HPQ DELL HPE QCOM MRVL AMD MU AMAT LRCX KLAC ASML GLW AVGO NXPI TER KEYS NI CHKP FTNT PPC LULU SIRI BBY TJX LOW HD CAT BA GD LMT RTX HON GE MMM AXP JPM BAC WFC C GS MS V MA PG KO PEP MCD SBUX VZ T CHTR TMUS AMGN BMY PFE JNJ MRK ABBV LLY GILD BIIB REGN VRTX AZN SNY NVS XOM CVX SHEL BABA JD NTES PDD EDU TAL BIDU VIPS CPRT

Cell Penetrating Peptide Market Forecast to Reach $8.12 Billion by 2033 | Astute Analytica

globenewswire.com
NVS

Regenerative Medicine Market Review 2020-2024 and Forecast 2025-2033: A $578.29 Bn Opportunity Says Astute Analytica

globenewswire.com
VRTX CRSP TMO ABBV AMGN NVS BDX

RET Fusion Targeted Therapies Market Set for Robust Growth by 2034 Amid Precision Oncology Shift | DelveInsight

prnewswire.com
MRK LLY RIGL AZN GILD ABBV PFE TMO BMY NVS BIIB

Next Generation Drug Conjugates Market Trends and Global Forecasts, 2025-2035 - Lutathera, Pluvicto, Givlaari, Oxlumo, Leqvio, and Amvuttra Represent Milestones in Advanced Treatment Solutions - ResearchAndMarkets.com

businesswire.com
NVS ALNY ARWR GERN IONS

CD137 Targeted Therapy Research Report 2026-2030: 90 Therapies in Clinical Trials, Upcoming Commercial Launches, Global & Regional Clinical & Commercial Trends,

globenewswire.com
GILD BMY REGN MRK PFE ABBV BIIB AZN AMGN NVS GMAB ABL BNTX

Molecular Switch Targeting Therapies Market Research Report 2026: Opportunities in Targeted Drug Delivery Systems and Therapies in Oncology, Autoimmune, Inflammatory, and Neurological Disorders

globenewswire.com
MRK BMY AZN PFE NVS LLY GILD JNJ REGN ABBV NVO SNY VRTX AMGN BIIB INCY EXEL SRPT CRSP EDIT NTLA ALNY MRNA BNTX COHR IMUX INSM CYTK KODK LULU NVDA GOOG MSFT IBM AMAT ILMN ALKS ACAD MNKD TEVA BHC XBI IBB XLF XLK XLV JAZZ ACGL

Cell and Gene Therapy Investment Trends Strategic Intelligence Report 2025: Market to Reach $63 Billion by 2031 - ResearchAndMarkets.com

businesswire.com
GILD NVS JNJ SRPT